More Steps Towards an Active Life After Stroke - ActForStroke

NCT06715566 · Status: NOT_YET_RECRUITING · Phase: NA · Type: INTERVENTIONAL · Enrollment: 50

Last updated 2024-12-04

No results posted yet for this study

Summary

The main goal of this quasi-experimental study is to prevent the negative consequences of mobility impairments after stroke. These include recurrent strokes, general deconditioning, and overweight on the physical side, and dependency, isolation, caregiver strain, and reduced quality of life from a psycho-social perspective.

ActForStroke, a combination of high-intensity gait training and subsequent remote coaching and activity monitoring, will contribute to more steps, higher activity levels and increased participation. ActForStroke requires minimal extra resources and can easily be implemented within existing staffing levels.

The investigators want to examine if patients who participate in the ActForStroke intervention are more active one year after stroke.

Patients with stroke will either participate in a combined intervention of high-intensity gait training and subsequent coaching to facilitate physical and social activity or receive standard care.

Conditions

  • Stroke Not Otherwise Specified

Interventions

BEHAVIORAL

ActForStroke

ActForStroke is a combination of 10 sessions high-intensity gait training and subsequent with up 7 coaching sessions until 1 year after stroke.

BEHAVIORAL

Standard care

Usual rehabilitation services

Sponsors & Collaborators

  • Regional Hospital Hammel Neurorehabilitation Centre

    collaborator UNKNOWN
  • University College Nordjylland

    collaborator UNKNOWN
  • University of Aarhus

    lead OTHER

Principal Investigators

  • Iris C. Brunner, Phd · Aarhus University, Hammel Neurocenter

  • Gunhild M. Hansen, PhD · University College Nord, Aalborg, Denmark

Study Design

Allocation
NON_RANDOMIZED
Purpose
TREATMENT
Masking
SINGLE
Model
PARALLEL

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2025-01-01
Primary Completion
2026-07-31
Completion
2026-12-31

Countries

  • Denmark

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT06715566 on ClinicalTrials.gov